SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002514
Filing Date
2015-11-09
Accepted
2015-11-09 16:15:11
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aegr-20150930x10q.htm 10-Q 2130966
2 EX-10.1 aegr-20150930ex101f352ed.htm EX-10.1 186521
3 EX-31.1 aegr-20150930ex31197c184.htm EX-31.1 11071
4 EX-31.2 aegr-20150930ex3121e5901.htm EX-31.2 11708
5 EX-32.1 aegr-20150930ex321807fb1.htm EX-32.1 8379
6 EX-32.2 aegr-20150930ex3228f5d93.htm EX-32.2 8067
  Complete submission text file 0001558370-15-002514.txt   7259355

Data Files

Seq Description Document Type Size
7 EX-101.INS aegr-20150930.xml EX-101.INS 1425614
8 EX-101.SCH aegr-20150930.xsd EX-101.SCH 42196
9 EX-101.CAL aegr-20150930_cal.xml EX-101.CAL 65888
10 EX-101.DEF aegr-20150930_def.xml EX-101.DEF 149800
11 EX-101.LAB aegr-20150930_lab.xml EX-101.LAB 360331
12 EX-101.PRE aegr-20150930_pre.xml EX-101.PRE 317519
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 151215775
SIC: 2834 Pharmaceutical Preparations